Literature DB >> 15218413

Familial and congenital polycythemias: a diagnostic approach.

Tom Van Maerken1, Kathleen Hunninck, Luc Callewaert, Yves Benoit, Geneviève Laureys, Joris Verlooy.   

Abstract

The rare absolute polycythemias with an innate and hereditary character can be grouped together under the heading "familial and congenital polycythemias" (FCPs). Primary forms, due to an intrinsic defect in the erythroid progenitor cells, and secondary forms, resulting from extrinsic factors such as an elevated erythropoietin level, have both been reported. Despite the widely divergent characteristics of the different FCPs, the range of possible diagnoses is much more restricted and the distribution of disorders markedly different compared with polycythemias in general. Therefore, in FCP, one can argue against following the algorithm of the Polycythemia Vera Study Group for the evaluation of an elevated hematocrit level, following instead a more specific algorithm. In this article the authors describe a child with primary FCP, review the different FCPs, and propose an adapted work-up scheme.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15218413     DOI: 10.1097/00043426-200407000-00002

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  2 in total

1.  EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors.

Authors:  Silverio Perrotta; Valeria Cucciolla; Marcella Ferraro; Luisa Ronzoni; Annunziata Tramontano; Francesca Rossi; Anna Chiara Scudieri; Adriana Borriello; Domenico Roberti; Bruno Nobili; Maria Domenica Cappellini; Adriana Oliva; Giovanni Amendola; Anna Rita Migliaccio; Patrizia Mancuso; Ines Martin-Padura; Francesco Bertolini; Donghoon Yoon; Josef T Prchal; Fulvio Della Ragione
Journal:  PLoS One       Date:  2010-08-05       Impact factor: 3.240

Review 2.  Advances in understanding the pathogenesis of primary familial and congenital polycythaemia.

Authors:  Lily J Huang; Yu-Min Shen; Gamze B Bulut
Journal:  Br J Haematol       Date:  2010-01-20       Impact factor: 6.998

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.